Возраст домена | 23 года |
Дата окончания | Истек срок регистрации |
PR | 5 |
ИКС | 10 |
Страниц в Google | 221000 |
Страниц в Яндексе | 10000 |
Dmoz | Да |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 173271 |
Alexa Country | 41486 |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales
pharmaceutical sales, device sales, pharma sales, medical sales, pharmaceutical news, drug rep, device rep
Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.
UTF-8
72.92 КБ
1 073
8 323 симв.
6 988 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
fiercepharma.com | 274 | 6 |
0 | 106975 | 20815 | |
biospace.com | 243 | 7 |
0 | 70695 | 19400 | |
fiercebiotech.com | 183 | 6 |
0 | 87045 | 19580 | |
medzilla.com | 161 | 6 |
0 | 1838553 | 442199 | |
medreps.com | 136 | 4 |
0 | 211392 | 43183 | |
massdevice.com | 91 | 5 |
0 | 145349 | 40453 | |
investorvillage.com | 80 | 4 |
10 | 124519 | 28848 | |
rinetki.com | 71 | n/a | 0 | Нет данных | Нет данных | |
pathologyblawg.com | 65 | 4 |
0 | 10265183 | Нет данных | |
fiercemedicaldevices.com | 62 | 6 |
10 | 217507 | 63771 | |
onyx.com | 5 | 6 |
110 | 830642 | 225168 | |
wikipedia.org | 4 | 9 |
0 | 5 | 6 | |
linkedin.com | 4 | 9 |
0 | 25 | 10 | |
glassdoor.com | 4 | 7 |
0 | 408 | 96 | |
bloomberg.com | 4 | 8 |
0 | 563 | 219 | |
facebook.com | 3 | 9 |
0 | 3 | 3 | |
indeed.com | 3 | 8 |
0 | 138 | 50 | |
convatec.com | 3 | 6 |
20 | 468507 | 210755 | |
twitter.com | 3 | 10 |
0 | 11 | 8 | |
Еще 31 сайт после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 11 Ноября 2016 ) | |
Количество ссылок на сайт | 5207 |
Количество доменов, которые ссылаются на сайт | 262 |
Количество найденных анкоров | 191 |
Исходящие (внешние) ссылки домена | 18249 |
Количество доменов, на которые ссылается сайт | 372 |
Количество исходящих анкоров | 5721 |
Внешние ссылки главной страницы ( 33 ) | |
forms.feedblitz.com/ajr | Click here to stay updated on CP happenings |
bit.ly/34d4WXo | Leukemia rivals try to stay ahead as Merck, Lilly chase |
bit.ly/348iqUj | For an 'acquisitive' Gilead, 2020 will be key test for CAR-T plans |
bit.ly/2PwMR1f | Foreign Drug Inspections Decline as FDA Hiring Struggles Continue |
bit.ly/2E8xF5g | Sanofi Is Paying a 172% Premium to Buy Synthorx -- and It Sounds Like a Good Deal for Both |
bit.ly/2YAl6ZC | 11-country survey of primary care physicians shows where U.S. is lagging and keeping pace |
bit.ly/2LGYh1p | Following Strong Phase III Results, BMS Plans to Seek Approval for AML Candidate CC-486 |
bit.ly/2RCGOed | Can a Breakthrough Medical Device Reduce the Risk of Hospital-Associated Infections? |
bit.ly/2RE93t6 | Sanofi CEO Hudson backs away from struggling diabetes, cardiovascular areas in strategy unveiling |
bit.ly/359id4E | FDA approves etectRx ‘digital pill’ as rivals struggle |
bit.ly/2E6CnjY | ICER Warns of ‘Short-Term Budget Challenges’ with Novo’s Rybelsus |
bit.ly/2P7Zxwv | Inscripta pushes funding to $260 million as they launch genome editing platform |
bit.ly/2YCmpHr | [release] ACTO Achieves 158% Year to Date Revenue Growth in 2019 and Has Digitally Transformed Over 50 Life Sciences Companies |
bit.ly/38ulsG3 | Latest CMS Data: Drug Spending is Not Skyrocketing; Hospitals and Physicians Dominate Healthcare Costs |
bit.ly/2YEtnf9 | Amgen rejigs Bay Area presence with deal for new R&D facility |
bit.ly/2YyORu1 | Apple's Wearables Business Expected to Overtake Mac in 2020 |
bit.ly/2P5sJnP | Is Congress Poised to Deal a Significant Blow to Hatch-Waxman and the Generic Drug Industry? |
bit.ly/35cOVlC | ASH: Sanofi eyes FDA filing as orphan blood drug hits late-phase goal |
bit.ly/2YyMlUw | US biosimilar launches about to turn a corner |
bit.ly/2E2ILbE | Novartis Kymriah demonstrates consistent efficacy and safety outcomes in US patients when used in real-world setting |
bit.ly/2shE2QJ | MedReps survey finds best companies to work for in 2020 |
pharma.elsevier.com/pharmacovigilance/pharmapendium-team-col... | PharmaPendium Team Collaborates with Pharma Companies on Drug-Drug Interaction Risk Calculator |
blogs.sciencemag.org/pipeline/archives/2019/12/10/the-hype-p... | The Hype Problem |
feeds.feedblitz.com/~/612682424/0/drugchannels~Latest-CMS-Da... | Latest CMS Data: Drug Spending is Not Skyrocketing; Hospitals and Physicians Dominate Healthcare Costs |
feeds.feedblitz.com/~/612509306/0/drugchannels~sPCMA-Busines... | sPCMA Business Forum 2020 |
blogs.sciencemag.org/pipeline/archives/2019/12/06/they-dont-... | They Don’t Know |
pharmexec.com/node/388953 | Are Field Sales Reps Getting a Bad Deal With Data? |
pharmexec.com/node/388954 | FDA Readies Modernized New Drug Review Operation |
//indeed.com/ | jobs by |
xtalks.com/host-a-webinar/?utm_source=Cafepharma&utm_medium=... | Want to host your own webinar? |
facebook.com/cafepharma | |
twitter.com/cafepharma | |
cafebanking.com | cafebanking |
Внутренние ссылки главной страницы ( 127 ) | |
/ | home |
cafepharma.com/contact | contact us |
cafepharma.com/boards | boards |
cafepharma.com/cafejobs | pharma jobs |
/jobratings | job ratings |
/cpwire/articles_list | cp wire |
/device | device news |
cafepharma.com/pharmagather | pharma blogs |
/catering | catering |
cafepharma.com/advertising | advertise |
/legalfirm-categories | Legal Help |
/user/login | login/register |
/content/december-10-2019-sanofi%E2%80%99s-new-ceo-unveils-n... | December 10 2019 - Sanofi’s new CEO unveils new strategies |
cafepharma.com/press-releases | submit a press release |
/taxonomy/term/10901 | Merck |
/taxonomy/term/10907 | Eli Lilly |
/category/news-tags/companies/abbvie | AbbVie |
/category/news-tags/jnj | JNJ |
/category/news-tags/imbruvica | Imbruvica |
/category/news-tags/companies/arq-531 | ARQ 531 |
/category/news-tags/companies/loxo-305 | LOXO-305 |
/category/news-tags/cll | CLL |
/category/news-tags/companies/ash2019 | ASH2019 |
/taxonomy/term/808 | M&A |
/category/news-tags/gilead-sciences | Gilead Sciences |
/category/news-tags/kite | Kite |
/taxonomy/term/35 | FDA |
/taxonomy/term/351 | drug manufacturing |
/category/news-tags/companies/foreign-drug-inspections | foreign drug inspections |
/taxonomy/term/11001 | Sanofi |
/category/news-tags/immuno-oncology | immuno-oncology |
/category/news-tags/companies/synthorx | Synthorx |
/taxonomy/term/680 | physicians |
/taxonomy/term/1311 | primary care |
/taxonomy/term/10895 | Bristol-Myers Squibb |
/category/news-tags/cc-486 | CC-486 |
/taxonomy/term/596 | AML |
/category/news-tags/companies/n8-medical | N8 Medical |
/category/news-tags/companies/cerashield | CeraShield |
/taxonomy/term/261 | devices |
/category/news-tags/companies/hospital-acquired-infections | hospital-acquired infections |
/category/news-tags/companies/paul-hudson | Paul Hudson |
/taxonomy/term/479 | Pharma CEOs |
/taxonomy/term/21 | diabetes |
/category/news-tags/companies/cardiovascular-death | cardiovascular death |
/category/news-tags/companies/digital-pill | digital pill |
/category/news-tags/companies/etectrx | etectRx |
/category/news-tags/companies/proteus | Proteus |
/category/news-tags/companies/id-cap | ID-Cap |
/category/news-tags/companies/abilify-mycite | Abilify MyCite |
/taxonomy/term/10924 | Novo Nordisk |
/category/news-tags/companies/rybelsus | Rybelsus |
/category/news-tags/companies/oral-semaglutide | oral semaglutide |
/category/news-tags/companies/icer | ICER |
/taxonomy/term/1529 | drug pricing |
/category/news-tags/companies/inscripta | Inscripta |
/category/news-tags/companies/genome-editing | genome editing |
/taxonomy/term/2642 | synthetic biology |
/category/news-tags/companies/acto | ACTO |
/category/news-tags/companies/cloud-platforms | cloud platforms |
/category/news-tags/companies/commercialization | commercialization |
/taxonomy/term/1600 | training |
/taxonomy/term/393 | sales reps |
/taxonomy/term/1734 | CMS |
/category/news-tags/drug-spending | drug spending |
/category/news-tags/hospitals | hospitals |
/taxonomy/term/10916 | Amgen |
/category/news-tags/companies/bay-area | Bay Area |
/category/news-tags/companies/san-francisco | San Francisco |
/taxonomy/term/456 | R&D |
/category/news-tags/apple | Apple |
/category/news-tags/companies/wearables | wearables |
/category/news-tags/hatch-waxman-act | Hatch Waxman Act |
/category/news-tags/legislation | legislation |
/category/news-tags/regulatory | regulatory |
/taxonomy/term/160 | generics |
/taxonomy/term/1775 | clinical trials |
/category/news-tags/companies/sutimlimab | sutimlimab |
/category/news-tags/companies/cold-agglutinin-disease | cold agglutinin disease |
/taxonomy/term/1597 | biosimilars |
/taxonomy/term/392 | Europe |
/taxonomy/term/10896 | Novartis |
/category/news-tags/companies/kymriah | Kymriah |
/category/news-tags/car-t | CAR-T |
/category/news-tags/companies/dlbcl | DLBCL |
/category/news-tags/companies/all | ALL |
/category/news-tags/companies/employees | employees |
/category/news-tags/companies/device-reps | device reps |
/taxonomy/term/775 | drug reps |
/category/news-tags/companies/employee-satisfaction | employee satisfaction |
/category/news-tags/companies/syneos-health | Syneos Health |
/category/news-tags/companies/teleflex-medical | Teleflex Medical |
/taxonomy/term/2652 | Conmed |
/front?page=1 | next › |
/front?page=2 | 3 |
/front?page=3 | 4 |
/front?page=4 | 5 |
/front?page=5 | 6 |
/front?page=6 | 7 |
/front?page=7 | 8 |
/front?page=8 | 9 |
/front?page=3007 | last » |
cafepharma.com/newsletters | Subscribe to one of our daily newsletters |
/cpwire/article/release-ACTO-Achieves-158-Year-to-Date-Reven... | [release] ACTO Achieves 158% Year to Date Revenue Growth in 2019 and Has Digitally Transformed Over 50 Life Sciences Companies |
/cpwire/article/MedReps-survey-finds-best-companies-to-work-... | MedReps survey finds best companies to work for in 2020 |
/cpwire/article/release-eyeforpharma-Awards-Recognize-Two-AC... | [release] eyeforpharma Awards Recognize Two ACTO Use Cases as Finalists |
/cpwire/article/Karuna-Therapeutics-Files-for-52-Million-Off... | Karuna Therapeutics Files for $52 Million Offering |
/cpwire/article/Biocept-Files-for-27-Million-Offering/72071- | Biocept Files for $27 Million Offering |
/cpwire/article/Highlights-2019-Cardiometabolic-Health-Congr... | Highlights: 2019 Cardiometabolic Health Congress, Chicago IL |
/cpwire/article/Microbiome-Report/71964- | Microbiome Report |
/cpwire/article/TELA-Bio-Files-for-69-Million-IPO/71783- | TELA Bio Files for $69 Million IPO |
/cpwire/article/Oyster-Point-Pharma-Files-for-85-Million-IPO... | Oyster Point Pharma Files for $85 Million IPO |
/cpwire/article/Cabaletta-Bio-Files-for-100-Million-IPO/7157... | Cabaletta Bio Files for $100 Million IPO |
/nasdaq_news/1541268 | ProQR Announces First Patient Dosed in Phase 1/2 Aurora Trial of QR-1123 for Autosomal Dominant Retinitis Pigmentosa |
/nasdaq_news/1541267 | Madrigal Pharmaceuticals Announces Pricing of Secondary Offering |
/nasdaq_news/1541266 | Onconova Therapeutics, Inc. Announces Closing of $5.0 Million Registered Direct Offering Priced At-the-Market |
/nasdaq_news/1541232 | Flow Cytometry Market Worth $4.1 billion by 2027- Exclusive Report by Meticulous Research® |
/nasdaq_news/1541231 | Equillium Granted U.S. FDA Fast Track Designation for Itolizumab for the Treatment of Lupus Nephritis |
/nasdaq_news/1541230 | MacroGenics Presents Flotetuzumab Data in Patients with Primary Induction Failure and Early Relapsed Acute Myeloid Leukemia at t... |
/nasdaq_news/1541229 | Onconova Therapeutics Announces Data on Genomic Profiles of Higher Risk Myelodysplastic Syndromes Patients Refractory to Azaciti... |
/nasdaq_news/1541195 | Onconova Therapeutics, Inc. Announces $5.0 Million Registered Direct Offering Priced At-the-Market |
/nasdaq_news/1541194 | Corvus Pharmaceuticals Presents Preclinical and Initial Clinical Data from the Phase 1/1b Trial of CPI-818 at the American Socie... |
/nasdaq_news/1541134 | Inceptua Medicines Access and Onconova Therapeutics Announce Pre-approval Access Collaboration for Rigosertib in Selected Countr... |
/privacy | privacy policy |
/terms | - |
cafepharma.com/boards/pages/pharma_biotech_trending_social_m... | social media-pharma |
cafepharma.com/boards/pages/med_device_trending_social_media... | social media-med device |
Domain Name: CAFEPHARMA.COM
Registry Domain ID: 76138564_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2017-08-18T11:47:57Z
Creation Date: 2001-08-17T18:40:18Z
Registrar Registration Expiration Date: 2018-08-17T18:40:15Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: +1.4806242505
Domain Status: clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited http://www.icann.org/epp#clientUpdateProhibited
Domain Status: clientRenewProhibited http://www.icann.org/epp#clientRenewProhibited
Domain Status: clientDeleteProhibited http://www.icann.org/epp#clientDeleteProhibited
Registry Registrant ID: Not Available From Registry
Registrant Name: Registration Private
Registrant Organization: Domains By Proxy, LLC
Registrant Street: DomainsByProxy.com
Registrant Street: 14455 N. Hayden Road
Registrant City: Scottsdale
Registrant State/Province: Arizona
Registrant Postal Code: 85260
Registrant Country: US
Registrant Phone: +1.4806242599
Registrant Phone Ext:
Registrant Fax: +1.4806242598
Registrant Fax Ext:
Registrant Email: CAFEPHARMA.COM@domainsbyproxy.com
Registry Admin ID: Not Available From Registry
Admin Name: Registration Private
Admin Organization: Domains By Proxy, LLC
Admin Street: DomainsByProxy.com
Admin Street: 14455 N. Hayden Road
Admin City: Scottsdale
Admin State/Province: Arizona
Admin Postal Code: 85260
Admin Country: US
Admin Phone: +1.4806242599
Admin Phone Ext:
Admin Fax: +1.4806242598
Admin Fax Ext:
Admin Email: CAFEPHARMA.COM@domainsbyproxy.com
Registry Tech ID: Not Available From Registry
Tech Name: Registration Private
Tech Organization: Domains By Proxy, LLC
Tech Street: DomainsByProxy.com
Tech Street: 14455 N. Hayden Road
Tech City: Scottsdale
Tech State/Province: Arizona
Tech Postal Code: 85260
Tech Country: US
Tech Phone: +1.4806242599
Tech Phone Ext:
Tech Fax: +1.4806242598
Tech Fax Ext:
Tech Email: CAFEPHARMA.COM@domainsbyproxy.com
Name Server: NS27.DOMAINCONTROL.COM
Name Server: NS28.DOMAINCONTROL.COM
>>> Last update of WHOIS database: 2017-09-12T18:00:00Z <<<
For more information on Whois status codes, please visit https://www.icann.org/resources/pages/epp-status-codes-2014-06-16-en
#
# robots.txt
#
# This file is to prevent the crawling and indexing of certain parts
# of your site by web crawlers and spiders run by sites like Yahoo!
# and Google. By telling these "robots" where not to go on your site,
# you save bandwidth and server resources.
#
# This file will be ignored unless it is at the root of your host:
# Used: http://example.com/robots.txt
# Ignored: http://example.com/site/robots.txt
#
# For more information about the robots.txt standard, see:
# http://www.robotstxt.org/wc/robots.html
#
# For syntax checking, see:
# http://www.sxw.org.uk/computing/robots/check.html
User-agent: *
Crawl-delay: 10
# Directories
Disallow: /includes/
Disallow: /misc/
Disallow: /modules/
Disallow: /profiles/
Disallow: /scripts/
Disallow: /themes/
Disallow: /xenbox/
# Files
Disallow: /CHANGELOG.txt
Disallow: /cron.php
Disallow: /INSTALL.mysql.txt
Disallow: /INSTALL.pgsql.txt
Disallow: /INSTALL.sqlite.txt
Disallow: /install.php
Disallow: /INSTALL.txt
Disallow: /LICENSE.txt
Disallow: /MAINTAINERS.txt
Disallow: /update.php
Disallow: /UPGRADE.txt
Disallow: /xmlrpc.php
# Paths (clean URLs)
Disallow: /admin/
Disallow: /comment/reply/
Disallow: /filter/tips/
Disallow: /node/add/
Disallow: /search/
Disallow: /user/register/
Disallow: /user/password/
Disallow: /user/login/
Disallow: /user/logout/
# Paths (no clean URLs)
Disallow: /?q=admin/
Disallow: /?q=comment/reply/
Disallow: /?q=filter/tips/
Disallow: /?q=node/add/
Disallow: /?q=search/
Disallow: /?q=user/password/
Disallow: /?q=user/register/
Disallow: /?q=user/login/
Disallow: /?q=user/logout/
Disallow: http://cafepharma.com/boards/threads/forest-reps-sue-over-sex-discrimination.506611/
США - 199.59.148.10
США - 199.59.148.82
США - 199.59.149.230
США - 199.59.150.39
HTTP/1.1 200 OK
Date: Wed, 11 Dec 2019 14:35:15 GMT
Server: Apache
X-Content-Type-Options: nosniff
X-Powered-By: PHP/5.6.36
Expires: Sun, 19 Nov 1978 05:00:00 GMT
Cache-Control: no-cache, must-revalidate
X-Content-Type-Options: nosniff
Content-Language: en
X-Frame-Options: SAMEORIGIN
X-Generator: Drupal 7 (http://drupal.org)
Link: ; rel="canonical",; rel="shortlink"
Vary: Accept-Encoding
Transfer-Encoding: chunked
Content-Type: text/html; charset=utf-8
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"